{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:24:23Z","timestamp":1773012263448,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006559","name":"University of Tsukuba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jtha.2022.09.002","type":"journal-article","created":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T06:17:48Z","timestamp":1673158668000},"page":"616-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Overlapping ADAMTS13 peptide binding profiles of DRB1\u221708:03 and DRB1\u221711:01 suggest a common etiology of immune-mediated thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-7931","authenticated-orcid":false,"given":"Kazuya","family":"Sakai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-414X","authenticated-orcid":false,"given":"Hiroko","family":"Miyadera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5768-1025","authenticated-orcid":false,"given":"Masayuki","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-7087","authenticated-orcid":false,"given":"Fumiaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-3126","authenticated-orcid":false,"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.09.002_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.09.002_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.20","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Kremer Hovinga","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2022.09.002_bib3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/jth.13956","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"16","author":"Kremer Hovinga","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.09.002_bib4","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood.V91.8.2839.2839_2839_2846","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura","volume":"91","author":"Furlan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.09.002_bib5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.09.002_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2009.03692.x","article-title":"Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link","volume":"8","author":"Scully","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.09.002_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1538-7836.2010.03772.x","article-title":"HLA-DRB1\u221711: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians","volume":"8","author":"Coppo","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.09.002_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00277-011-1384-z","article-title":"The role of human leukocyte antigens as predisposing and\/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura","volume":"91","author":"John","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2022.09.002_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156679","article-title":"Thrombotic thrombocytopenic purpura in black people: impact of ethnicity on survival and genetic risk factors","volume":"11","author":"Martino","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jtha.2022.09.002_bib10","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood.2020005395","article-title":"HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR","volume":"135","author":"Sakai","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.09.002_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757192","article-title":"Emerging concepts in immune thrombotic thrombocytopenic purpura","volume":"12","author":"Laghmouchi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2022.09.002_bib12","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1182\/blood-2012-09-456780","article-title":"Preferential HLA-DRB1\u221711-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells","volume":"121","author":"Sorvillo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.09.002_bib13","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3324\/haematol.2015.136671","article-title":"The ADAMTS13(1239-1253) peptide is a dominant HLA-DR1-restricted CD4(+) T-cell epitope","volume":"102","author":"Gilardin","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.09.002_bib14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3324\/haematol.2017.179119","article-title":"Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ","volume":"103","author":"Hrdinova","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.09.002_bib15","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood-2015-10-668053","article-title":"CD4+ T cells from patients with acquired thrombotic thrombocytopenic purpura recognize CUB2 domain-derived peptides","volume":"127","author":"Verbij","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2022.09.002_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"Jensen","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.jtha.2022.09.002_bib17","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","article-title":"Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data","volume":"19","author":"Reynisson","year":"2020","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.jtha.2022.09.002_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI74961","article-title":"Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA","volume":"125","author":"Miyadera","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2022.09.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12667\/mhc.8.1","article-title":"Analysis of HLA haplotypes in Japanese, using high resolution allele typing","volume":"8","author":"Nakajima","year":"2001","journal-title":"Major Histocompatibility Complex"},{"key":"10.1016\/j.jtha.2022.09.002_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-0039.1994.tb02375.x","article-title":"Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals","volume":"44","author":"Hashimoto","year":"1994","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jtha.2022.09.002_bib21","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2022.09.002_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2022.09.002_bib23","article-title":"HLA-modeler: automated homology modeling of human leukocyte antigens","volume":"2013","author":"Amari","year":"2013","journal-title":"Int J Med Chem"},{"key":"10.1016\/j.jtha.2022.09.002_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1273\/cbij.20.1","article-title":"HLABAP: HLA Class I-binding antigenic peptide predictor","volume":"20","author":"Kataoka","year":"2020","journal-title":"Chem-Bio Inform J"},{"key":"10.1016\/j.jtha.2022.09.002_bib25","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1038\/s41467-021-26646-5","article-title":"Reversion analysis reveals the in\u00a0vivo immunogenicity of a poorly MHC I-binding cancer neoepitope","volume":"12","author":"Ebrahimi-Nik","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2022.09.002_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","article-title":"Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics","volume":"31","author":"Kitamura","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtha.2022.09.002_bib27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.gt.3301206","article-title":"Plat-E: an efficient and stable system for transient packaging of retroviruses","volume":"7","author":"Morita","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.jtha.2022.09.002_bib28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtha.2022.09.002_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1399-0039.2007.00867.x","article-title":"Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis","volume":"70","author":"Thomson","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jtha.2022.09.002_bib30","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-009-1539-9","article-title":"Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset","volume":"52","author":"Kawabata","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jtha.2022.09.002_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.autrev.2018.05.013","article-title":"Celiac disease and endocrine autoimmunity \u2013 the genetic link","volume":"17","author":"Kahaly","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtha.2022.09.002_bib32","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/jc.2018-01621","article-title":"HLA-DQB1 position 57 defines susceptibility to isolated and polyglandular autoimmunity in adults: interaction with gender","volume":"104","author":"Kraus","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jtha.2022.09.002_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.178.1.27","article-title":"Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles","volume":"178","author":"Chicz","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2022.09.002_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF02199809","article-title":"Natural peptides isolated from Gly86\/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52","volume":"43","author":"Verreck","year":"1996","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jtha.2022.09.002_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri1805","article-title":"MHC class II proteins and disease: a structural perspective","volume":"6","author":"Jones","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2022.09.002_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/1074-7613(95)90170-1","article-title":"Low avidity recognition of self-antigen by T cells permits escape from central tolerance","volume":"3","author":"Liu","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2022.09.002_bib37","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.2337\/db08-0530","article-title":"Low-affinity major histocompatibility complex-binding peptides in type 1 diabetes","volume":"57","author":"James","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jtha.2022.09.002_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.681062","article-title":"Strategies to use nanoparticles to generate CD4 and CD8 regulatory T cells for the treatment of SLE and other autoimmune diseases","volume":"12","author":"Horwitz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2022.09.002_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biomaterials.2015.04.003","article-title":"Paracrine co-delivery of TGF-\u03b2 and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells","volume":"59","author":"McHugh","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jtha.2022.09.002_bib40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/art.40773","article-title":"Suppression of murine lupus by CD4+ and CD8+ treg cells induced by T cell-targeted nanoparticles loaded with interleukin-2 and transforming growth factor \u03b2","volume":"71","author":"Horwitz","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtha.2022.09.002_bib41","article-title":"Multiple sclerosis: LIFNano-CD4 for trojan horse delivery of the neuro-protective biologic \u201cLIF\u201d into the brain: preclinical proof of concept","volume":"3","author":"de la Flor","year":"2021","journal-title":"Front Med Technol"},{"key":"10.1016\/j.jtha.2022.09.002_bib42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2022.09.002_bib43","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41467-019-09893-5","article-title":"Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines","volume":"10","author":"Umeshappa","year":"2019","journal-title":"Nat Commun"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:37:34Z","timestamp":1761536254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622071707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1538783622071707"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.09.002","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlapping ADAMTS13 peptide binding profiles of DRB1\u221708:03 and DRB1\u221711:01 suggest a common etiology of immune-mediated thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}